Table 1.
Characteristics with stage IV endometrial carcinoma patients.
| Characteristic | No early death N=1741 | All-cause early death N=299 | Cancer-specificearly death N=282 |
|---|---|---|---|
| Age | |||
| ≤55 | 498 (29%) | 48 (16%) | 48 (17%) |
| 56–74 | 968 (56%) | 164 (55%) | 153 (54%) |
| ≥75 | 275 (16%) | 87 (29%) | 81 (29%) |
| Race | |||
| White patients | 1,330 (76%) | 223 (75%) | 213 (76%) |
| African American | 223 (13%) | 41 (14%) | 36 (13%) |
| Others* | 188 (11%) | 35 (12%) | 33 (12%) |
| Insurance | |||
| Uninsured | 61 (3.5%) | 16 (5.4%) | 16 (5.7%) |
| Insured | 1,356 (78%) | 214 (72%) | 200 (71%) |
| Unknown | 324 (19%) | 69 (23%) | 66 (23%) |
| Marital status | |||
| Unmarried | 395 (23%) | 62 (21%) | 57 (20%) |
| Married | 790 (45%) | 110 (37%) | 104 (37%) |
| Divorced or Separated | 215 (12%) | 35 (12%) | 35 (12%) |
| Widowed | 274 (16%) | 84 (28%) | 78 (28%) |
| Unknown | 67 (3.8%) | 8 (2.7%) | 8 (2.8%) |
| Tumor size(mm) | |||
| ≤59 | 814 (47%) | 95 (32%) | 93 (33%) |
| 60-105 | 695 (40%) | 126 (42%) | 116 (41%) |
| ≥106 | 232 (13%) | 78 (26%) | 73 (26%) |
| Histology grade | |||
| GI-II | 492 (28%) | 38 (13%) | 34 (12%) |
| GIII-IV | 956 (55%) | 198 (66%) | 188 (67%) |
| Unknown | 293 (17%) | 63 (21%) | 60 (21%) |
| Histological classification | |||
| Endometrioid endometrial carcinoma | 1,099 (63%) | 148 (49%) | 139 (49%) |
| Non-endometrioid endometrial carcinoma | 642 (37%) | 151 (51%) | 143 (51%) |
| Lymph node | |||
| No regional lymph node involvement | 1,021 (59%) | 150 (50%) | 140 (50%) |
| Regional lymph node involvement | 720 (41%) | 149 (50%) | 142 (50%) |
| Bone-metastases | |||
| No | 926 (53%) | 140 (47%) | 129 (46%) |
| Yes | 72 (4.1%) | 29 (9.7%) | 29 (10%) |
| Unknown | 743 (43%) | 130 (43%) | 124 (44%) |
| Brain-metastases | |||
| No | 975 (56%) | 160 (54%) | 150 (53%) |
| Yes | 23 (1.3%) | 8 (2.7%) | 8 (2.8%) |
| Unknown | 743 (43%) | 131 (44%) | 124 (44%) |
| Liver-metastases | |||
| No | 915 (53%) | 129 (43%) | 120 (43%) |
| Yes | 84 (4.8%) | 44 (15%) | 42 (15%) |
| Unknown | 742 (43%) | 126 (42%) | 120 (43%) |
| Lung-metastases | |||
| No | 785 (45%) | 93 (31%) | 86 (30%) |
| Yes | 214 (12%) | 77 (26%) | 73 (26%) |
| Unknown | 742 (43%) | 129 (43%) | 123 (44%) |
| Surgery | |||
| No | 167 (9.6%) | 128 (43%) | 122 (43%) |
| Yes | 1,574 (90%) | 171 (57%) | 160 (57%) |
| Radiation | |||
| No | 1,308 (75%) | 279 (93%) | 263 (93%) |
| Yes | 433 (25%) | 20 (6.7%) | 19 (6.7%) |
| Chemotherapy | |||
| No | 433 (25%) | 233 (78%) | 221 (78%) |
| Yes | 1,308 (75%) | 66 (22%) | 61 (22%) |
Statistics presented: n (%); *American Indian/AK Native, Asian/Pacific Islander.